News Focus
News Focus
Followers 137
Posts 10066
Boards Moderated 0
Alias Born 04/13/2007

Re: AliAngel post# 695

Wednesday, 12/09/2009 2:27:34 PM

Wednesday, December 09, 2009 2:27:34 PM

Post# of 1241
And dont forget $55 million in revenues for AVMD. Most companies trade at a valuation of at least 1x revenues which would put the share price over a $1.00. Right now the market cap is only $3.5 million. For those concerned about Australia the company did $10 million in England having only been there one year. Not only that but the company said they would abide by any changes in the laws in Australia so it is not like they are going out of business there. They will just have to change some of their practices if the laws are changed. In addition 50% of their sales came from clinics as opposed to over the phone so those should be unaffected. Also more than 50% of their sales are treatments for premature ejaculation where there is no known competition and a smaller percentage of their sales are coming from the erectile dysfunction treatment which was the major "bone" (no pun intended) of contention because the Australian govt viewed ED as a more serious health concern which they feel needs a direct face to face consult. This company is similar to the Boston Consulting Group which has ED and PE clinics across the US. Its not like they are practicing witchcraft. A nasal spray for ED and PE is better imo because the drug never enters the digestive tract and hence fewer side effects than an oral med. Sincerely, Dr. Ruth.....

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now